We are live on ! Find out more
HC

Henshaw Capital Portfolio holdings

AUM $3.07B
1-Year Est. Return 40.85%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$1.44B
AUM Growth
-$266M
Cap. Flow
-$4.59M
Cap. Flow %
-0.32%
Top 10 Hldgs %
33.34%
Holding
325
New
10
Increased
75
Reduced
47
Closed
24

Top Buys

Rank Stock Value
1
BURL icon
Burlington
BURL
+$598K
2
TFX icon
Teleflex
TFX
+$547K
3
GDDY icon
GoDaddy
GDDY
+$471K
4
BMY icon
Bristol-Myers Squibb
BMY
+$452K
5
XMTR icon
Xometry
XMTR
+$416K

Top Sells

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$999K
2
C icon
Citigroup
C
+$675K
3
WRB icon
W.R. Berkley
WRB
+$655K
4
CSL icon
Carlisle Companies
CSL
+$506K
5
WSC icon
WillScot Mobile Mini Holdings
WSC
+$502K

Sector Composition

Rank Sector Weight
1 Technology 24.14%
2 Industrials 16.41%
3 Healthcare 12.77%
4 Financials 11.85%
5 Communication Services 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBH icon
151
Prestige Consumer Healthcare
PBH
$2.49B
$473K 0.03%
8,052
– –
EQNR icon
152
Equinor
EQNR
$98.2B
$472K 0.03%
13,569
-848
-6% -$30.3K
FIBK icon
153
First Interstate BancSystem
FIBK
$3.53B
$463K 0.03%
12,150
– –
PPG icon
154
PPG Industries
PPG
$25.4B
$460K 0.03%
4,022
+20
+0.5% +$2.5K
BMY icon
155
Bristol-Myers Squibb
BMY
$136B
$457K 0.03%
+5,930
New +$452K
MTX icon
156
Minerals Technologies
MTX
$2.24B
$446K 0.03%
7,263
+186
+3% +$11.9K
WCC
157
WESCO International
WCC
$16.4B
$444K 0.03%
4,149
-709
-15% -$87.4K
SWAV
158
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$440K 0.03%
2,300
– –
EFOR
159
Everforth Inc
EFOR
$1.31B
$431K 0.03%
4,781
+633
+15% +$64.9K
WSFS icon
160
WSFS Financial
WSFS
$4B
$416K 0.03%
10,366
– –
NDAQ icon
161
Nasdaq
NDAQ
$55.5B
$413K 0.03%
8,115
+30
+0.4% +$1.59K
SNY icon
162
Sanofi
SNY
$107B
$412K 0.03%
8,228
– –
XMTR icon
163
Xometry
XMTR
$5.39B
$410K 0.03%
+12,070
New +$416K
DD icon
164
DuPont de Nemours
DD
$18.5B
$408K 0.03%
5,854
– –
CL icon
165
Colgate-Palmolive
CL
$72.3B
$407K 0.03%
5,079
– –
CVX icon
166
Chevron
CVX
$396B
$399K 0.03%
2,754
-66
-2% -$10.9K
WMS icon
167
Advanced Drainage Systems
WMS
$10.3B
$398K 0.03%
4,424
– –
MYRG icon
168
MYR Group
MYRG
$4.58B
$395K 0.03%
4,477
– –
TVTX icon
169
Travere Therapeutics
TVTX
$6.19B
$393K 0.03%
16,232
– –
TEAM icon
170
Atlassian
TEAM
$48.2B
$390K 0.03%
2,082
+521
+33% +$111K
WNS
171
DELISTED
WNS Holdings
WNS
$387K 0.03%
5,189
– –
HALO icon
172
Halozyme
HALO
$12B
$387K 0.03%
8,792
– –
LOW icon
173
Lowe's Companies
LOW
$117B
$382K 0.03%
2,185
– –
VOD icon
174
Vodafone
VOD
$37.1B
$381K 0.03%
24,479
– –
JJSF icon
175
J&J Snack Foods
JJSF
$1.67B
$380K 0.03%
2,724
– –
5 6
7
8 9

Similar funds

DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $3.07B AUM 16.75% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CI
Capital International Los Angeles, California $3.06B AUM 33.84% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Henshaw Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Henshaw Capital held 325 positions worth $1.44B, down 16% from $1.71B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Henshaw Capital's Q2 2022 filing shows 10 new, 75 increased, 47 reduced and 24 closed positions. Its largest new stake was Bristol-Myers Squibb: 5,930 shares worth $457K. The largest sale was Dentsply Sirona, an estimated $999K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Henshaw Capital's largest Q2 2022 buy was Bristol-Myers Squibb: 5,930 shares worth $457K.
  • Henshaw Capital added most to Burlington in Q2 2022, an estimated $598K increase.
  • Henshaw Capital's biggest Q2 2022 reduction was Citigroup, cutting an estimated $675K.
  • Henshaw Capital fully exited Dentsply Sirona in Q2 2022, selling an estimated $999K.
  • Henshaw Capital's ten largest holdings make up 33% of its $1.44B portfolio in Q2 2022.
  • Henshaw Capital opened 10 new positions and closed 24 in Q2 2022.
  • Henshaw Capital's portfolio value fell 16% quarter-over-quarter to $1.44B.

Based on Henshaw Capital's 13F filing for Q2 2022, filed 28 May 2026.